Peter M Strumph - Chief Executive Officer, Nile Therapeutics, Inc

As of January 20, 2009


Peter M Strumph Net Worth

  • Net worth is estimated to be at least $1.43M
  • Owns at least 7,780 units of Nile Therapeutics, Inc stock

Peter M Strumph Trading

  • Largest purchase of shares was 3,000 units , worth over $2.58K on December 12, 2008
  • In total has made about 3 transactions over a year
  • Usually trades in December, with the busiest year in 2008
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Peter M Strumph Mailing Address

  • Mailing address is Codexis, Inc. 200 Penobscot Drive Redwood City CA 94063 CA

Nile Therapeutics, Inc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Jonathan DrachmanJonathan Drachman 2020 $4,468,538 $4,468,538 $4,468,538 - $4,468,538
Jonathan DrachmanJonathan Drachman 2019 $3,823,038 $3,823,038 $3,823,038 - $3,823,038
Robert Ho 2020 $2,654,271 $2,654,271 $2,654,271 - $2,654,271
Holly Vance 2020 $2,091,819 $2,091,819 $2,091,819 - $2,091,819
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1404644/000119312521102235/d129921ddef14a.htm

Nile Therapeutics, Inc Insider Trading

  • The most recent transaction was 150,000 units bought on August 26, 2021 by Jonathan Drachman worth over $933.55K
  • In the last 13 years, insiders at Nile Therapeutics, Inc sold an estimated value of $717.35K and bought an estimated value of $37.07M
  • The most active traders are Carl Walkey, Senior Vice President,  Daron Evans, Chief Financial Officer,  and Joshua A Kazam, President & CEO
  • Insider trading is most common in July, with the busiest year in 2021

Neoleukin Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1